Large-scale testing (Phase 3)Study completedNCT00742469What this trial is testingRifaximin for Prevention of Travellers' DiarrheaWho this might be right forDiarrhea Bausch Health Americas, Inc. 210
Not applicableUnknownNCT02040922What this trial is testingCampylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and MicrobiotaWho this might be right forCampylobacter InfectionsIrritable Bowel Syndrome University of Nottingham 450
Not applicableLooking for participantsNCT03223077What this trial is testingMucosal and Microbiota Changes During Acute CampylobacteriosisWho this might be right forIrritable Bowel Syndrome Mayo Clinic 150
Not applicableStudy completedNCT03266068What this trial is testingEpidemiology and Pathophysiology of Post-Infectious Functional GI DisordersWho this might be right forCampylobacter InfectionsIrritable Bowel Syndrome Mayo Clinic 120
Large-scale testing (Phase 3)Study completedNCT03683667What this trial is testingProtein Plus: Improving Infant Growth Through Diet and Enteric HealthWho this might be right forStuntingMalnutrition; ProteinEnteric Pathogens+1 more Johns Hopkins Bloomberg School of Public Health 5,283
Early research (Phase 1)Study completedNCT02067676What this trial is testingSafety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused DiarrheaWho this might be right forCampylobacter Infection U.S. Army Medical Research and Development Command 48
Not applicableStudy completedNCT02105714What this trial is testingDiagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive DisordersWho this might be right forSoil-transmitted HelminthiasisSchistosomiasisStrongyloidiasis+8 more Swiss Tropical & Public Health Institute 2,800
Early research (Phase 1)UnknownNCT00434798What this trial is testingCampylobacter Jejuni Challenge Model Development: Dose Ranging StudyWho this might be right forCampylobacter Infections University of Vermont 50
Early research (Phase 1)UnknownNCT01048112What this trial is testingCampylobacter Jejuni Challenge Model Development: Assessment of Homologous ProtectionWho this might be right forCampylobacter Infections University of Vermont 16
Large-scale testing (Phase 3)Study completedNCT02280044What this trial is testingEfficacy of Rifaximin in Preventing CampylobacteriosisWho this might be right forDysenteryDiarrheaEnteric Campylobacteriosis Johns Hopkins Bloomberg School of Public Health 30
Testing effectiveness (Phase 2)Study completedNCT04182490What this trial is testingLMN-101 in a Campylobacter Human Challenge ModelWho this might be right forCampylobacter Infections Lumen Bioscience, Inc. 42
Testing effectiveness (Phase 2)UnknownNCT00859716What this trial is testingACE393-103 Vaccination Challenge StudyWho this might be right forCampylobacter Infection TD Vaccines A/S 72
Early research (Phase 1)Study completedNCT05500417What this trial is testingSafety and Immunogenicity of CJCV2 With and Without ALFQWho this might be right forCampylobacter Infection National Institute of Allergy and Infectious Diseases (NIAID) 59
Early research (Phase 1)Study completedNCT04098263What this trial is testingSafety and Pharmacokinetic Study of LMN-101 in Healthy VolunteersWho this might be right forCampylobacter Jejuni Infection Lumen Bioscience, Inc. 21
Not applicableUnknownNCT06425250What this trial is testingCampylobacter Spp. Bone and Joint Infection: a Retrospective Cohort StudyWho this might be right forCampylobacter Infections Hospices Civils de Lyon 200
Not applicableUnknownNCT06432777What this trial is testingRecurrent Campylobacter Bacteraemia in Immunocompromised PatientsWho this might be right forCampylobacter Infections Hospices Civils de Lyon 30
Not applicableStudy completedNCT02884752What this trial is testingRetrospective Study of Bone Infection Due to Campylobacter SppWho this might be right forCampylobacter InfectionsBone Diseases, Infectious University Hospital, Brest 10